| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to the pharmaceutical industry and represents a product in the form of a kit containing the first composition containing a compound specified in azelaic acid or its salts in an amount of approximately 5 wt % to 10 wt % of the total weight of the first composition, and the second composition different from the first one and containing a compound specified in a group consisting of brimonidine or its salts, in an amount of approximately 0.1 wt % to 0.2 wt % of the total weight of the second composition, as a combined product used as a therapeutic agent for treating inflammatory skin diseases, wherein the first and second compositions can be used either simultaneously, separately or at a time delay.EFFECT: invention provides the more effective treatment of the inflammatory skin diseases than the treatment using each compound separately with the minimum side effect notwithstanding the time of using the above combination.13 cl, 7 ex |
